Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro.

Since cancer cells, when grown as spheroids, display drug sensitivity and radiation resistance patterns such as seen in vivo we recently established a three‑dimensional (3D) in vitro model recapitulating colorectal cancer (CRC)-triggered lymphatic endothelial cell (LEC)‑barrier breaching to study mechanisms of intra‑/extravasation. CRC metastasizes not only through lymphatics but also through blood vessels and here we extend the 3D model to the interaction of blood endothelial cells (BECs) with naïve and 5‑fluorouracil (5‑FU)‑resistant CRC CCL227 cells. The 3D model enabled quantifying effects of tumour‑derived microRNA200 (miR200) miR200a, miR200b, miR200c, miR141 and miR429 regarding the induction of so-called 'circular chemorepellent‑induced defects' (CCIDs) within the BEC‑barrier, which resemble gates for tumour transmigration. For this, miR200 precursors were individually transfected and furthermore, the modulation of ZEB family expression was analysed by western blotting. miR200c, miR141 and miR429, which are contained in exosomes from naïve CCL227 cells, downregulated the expression of ZEB2, SNAI and TWIST in BECs. The exosomes of 5‑FU‑resistant CCL227‑RH cells, which are devoid of miR200, accelerated CCID formation in BEC monolayers as compared to exosomes from naïve CCL227 cells. This confirmed the reported role of ZEB2 and SNAI in CRC metastasis and highlighted the active contribution of the stroma in the metastatic process. CCL227 spheroids affected the integrity of BEC and LEC barriers alike, which was in agreement with the observation that CRC metastasizes via blood stream (into the liver) as well as via lymphatics (into lymph nodes and lungs). This further validated the CRC/LEC and CRC/BEC in vitro model to study mechanisms of CRC spreading through vascular systems. Treatment of CCL227‑RH cells with the HDAC inhibitors mocetinostat and sulforaphane reduced CCID formation to the level triggered by naïve CCL227 spheroids, however, without significantly influencing miR200 expression in CCL227-RH cells.

[1]  W. Jäger,et al.  NF-κB contributes to MMP1 expression in breast cancer spheroids causing paracrine PAR1 activation and disintegrations in the lymph endothelial barrier in vitro , 2015, Oncotarget.

[2]  J. Herranz,et al.  A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy , 2015, Oncotarget.

[3]  T. Keck,et al.  ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat , 2015, EMBO molecular medicine.

[4]  W. Jäger,et al.  Loss of miR-200 family in 5-fluorouracil resistant colon cancer drives lymphendothelial invasiveness in vitro. , 2015, Human molecular genetics.

[5]  Jianlin Ren,et al.  Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression , 2015, BMC Cancer.

[6]  Ming Liu,et al.  P-Akt/miR‑200 signaling regulates epithelial-mesenchymal transition, migration and invasion in circulating gastric tumor cells. , 2014, International journal of oncology.

[7]  Yu Ding,et al.  miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2. , 2014, World journal of gastroenterology.

[8]  V. Findlay,et al.  Epithelial to mesenchymal transition and the cancer stem cell phenotype: Insights from cancer biology with therapeutic implications for colorectal cancer , 2014, Cancer Gene Therapy.

[9]  A. Díaz-López,et al.  A core microRNA signature associated with inducers of the epithelial‐to‐mesenchymal transition , 2014, The Journal of pathology.

[10]  Gregory J Goodall,et al.  Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression. , 2013, Neoplasia.

[11]  I. Nagtegaal,et al.  MicroRNAs in colorectal cancer metastasis , 2011, The Journal of pathology.

[12]  W. Jäger,et al.  NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells , 2011, British Journal of Cancer.

[13]  D. Steinhilber,et al.  Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. , 2011, The Journal of clinical investigation.

[14]  W. Berger,et al.  Relevance of microRNA modulation in chemoresistant colon cancer in vitro. , 2011, International journal of clinical pharmacology and therapeutics.

[15]  David B Jackson,et al.  EMT is the dominant program in human colon cancer , 2011, BMC Medical Genomics.

[16]  W. Mikulits,et al.  Long-term persistence of acquired resistance to 5-fluorouracil in the colon cancer cell line SW620. , 2010, Experimental cell research.

[17]  T. Szekeres,et al.  Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro , 2010, British Journal of Cancer.

[18]  A. G. de Herreros,et al.  Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer. , 2009, Carcinogenesis.

[19]  A. G. de Herreros,et al.  A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. , 2008, Genes & development.

[20]  E. Ho,et al.  Dietary histone deacetylase inhibitors: from cells to mice to man. , 2007, Seminars in cancer biology.

[21]  E. Ho,et al.  Sulforaphane Retards the Growth of Human PC-3 Xenografts and Inhibits HDAC Activity in Human Subjects , 2007, Experimental biology and medicine.

[22]  E. Ho,et al.  Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apcmin mice , 2006 .

[23]  G. Williamson,et al.  Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cells. , 2004, Carcinogenesis.

[24]  A. Soleiman,et al.  Telomerase‐Immortalized Lymphatic and Blood Vessel Endothelial Cells are Functionally Stable and Retain Their Lineage Specificity , 2004, Microcirculation.